Shanghai Minjin Investment
VC Fund
Shanghai Minjin Investment is a VC fund focused on Biopharma and Biotechnology. Shanghai Minjin Investmentis an investment firm.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Shanghai Minjin Investment invests in
Stages Shanghai Minjin Investment invests in
Countries Shanghai Minjin Investment invests in
Investment Focus
Industry
- Biopharma 3 (38%)
- Biotechnology 3 (38%)
- Pharmaceutical 2 (25%)
- Aerospace 1 (13%)
- Industrial 1 (13%)
Stage
- Series C 3 (38%)
- Seed 2 (25%)
- Series A 2 (25%)
- Series B 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. | Series B / Jul 03, 2026 | |
|
|
Niantong Intelligence is specialized in high-performance brain-computer interface (BCI) technology and neuro-rehabilitation medical devices.the company commercializes academic research into specialized hardware and software solutions. Their tech stack integrates EEG, EMG, functional near-infrared spectroscopy (fNIRS), and electrical stimulationsystems to assist with limb function recovery and reconstruction. Their flagship product, the eCon-Hand, is a brain-controlled wireless exoskeleton glove designed to decode movement intentions and assist stroke patients with active hand rehabilitation. | $14.7M / Series A / Jul 02, 2026 | |
|
|
Gnosis Healthineer provides medical devices to hospitals such as Clinical EEG AI Model. It builds an EEG data center for second- and third-level general hospitals to solve the problem of insufficient EEG data storage. The hardware construction of the data center includes: PB-level storage and servers, and high-performance computing equipment. | $14.8M / Series A / Jun 05, 2026 | |
|
|
The aim of Shuyin Intelligent is to realize our grand vision of global health and well-being by accelerating the growth of the biomedical industry and developing and producing cutting-edge medications that treat illnesses, prolong life, and enhance quality of life. | Seed / Jun 02, 2026 | |
|
|
Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease. | $73.8M / Series C / May 29, 2026 | |
|
|
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft. | $147.4M / Series C / May 27, 2026 | |
|
|
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | $72.6M / Series C / Apr 01, 2026 | |
|
|
Weiyi Technology specializes in intelligent core motion components. | Seed / Mar 30, 2026 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shanghai Minjin Investment invest in?
Shanghai Minjin Investment invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Series C and Seed stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Shanghai Minjin Investment last invest?
The most recent investment recorded for Shanghai Minjin Investment closed in Jul 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!